For: | Chen P, Yang HD, Wang JJ, Zhu ZH, Zhao HM, Yin XY, Cai Y, Zhu HL, Fu JL, Zhang XZ, Sun WX, Hui L, Zhang XB. Association of serum interleukin-6 with negative symptoms in stable early-onset schizophrenia. World J Psychiatry 2024; 14(6): 794-803 [PMID: 38984340 DOI: 10.5498/wjp.v14.i6.794] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v14/i6/794.htm |
Number | Citing Articles |
1 |
Jiali Luo, Junjiao Ping, Jing Wan, Jianli Zhu, Ying Zhang, Jie Zhang, Tingyun Jiang. Association of Serum SOCS3 and Inflammatory Marker Levels With Cognitive Function in First‐Episode Schizophrenia. International Journal of Developmental Neuroscience 2025; 85(4) doi: 10.1002/jdn.70027
|
2 |
Maja Pantovic-Stefanovic, Milica Velimirovic, Vladimir Jurisic, Marija Puric, Marta Gostiljac, Sara Dodic, Ivana Minic, Milica Nesic, Tatjana Nikolic, Natasa Petronijevic, Maja Ivkovic, Bojana Dunjic-Kostic. Exploring the role of TNF-α, TGF-β, and IL-6 serum levels in categorical and noncategorical models of mood and psychosis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-73937-0
|
3 |
Jingyuan Li, Fangyu Chen. Efficacy and safety evaluation of olanzapine treatment for schizophrenia patients: A retrospective data analysis. Archives of Psychiatric Nursing 2025; 54: 26 doi: 10.1016/j.apnu.2024.12.005
|